Skip to content
Review

NAMPT beyond NAD+ biosynthesis: roles in tumor microenvironment remodeling and cancer progression.

Aug 2026 · Biochemical Pharmacology · pp. 118344 · 0 citations · 95 references
Medicine

TL;DR

The multifaceted pro-tumorigenic mechanisms through which nicotinamide phosphoribosyltransferase (NAMPT) regulates key features of the TME, including macrophage polarization and immune responses, metabolic reprogramming and TME acidification, angiogenesis, and the maintenance of epithelial-mesenchymal transition and cancer stemness are summarized.

Abstract

The tumor microenvironment (TME) is characterized by chronic inflammation, high metabolic activity, and aberrant vascular function, which together create an ecosystem that supports tumor progression. In this review, we summarize the multifaceted pro-tumorigenic mechanisms through which nicotinamide phosphoribosyltransferase (NAMPT) regulates key features of the TME, including macrophage polarization and immune responses, metabolic reprogramming and TME acidification, angiogenesis, and the maintenance of epithelial-mesenchymal transition and cancer stemness. These interconnected processes collectively shape TME evolution and promote malignant progression. We also integrate recent structural insights into NAMPT catalytic architecture and ligand-bound inhibitory and activating complexes, highlighting the structural basis for NAMPT druggability. We further discuss recent advances in therapeutic strategies targeting NAMPT in cancer, including natural products, small-molecule inhibitors, and RNA-based approaches, and we highlight current challenges and future directions in the field. A deeper understanding of the complex roles of NAMPT in the TME will be essential for shifting anticancer therapy from direct tumor cell killing toward systemic reprogramming of the tumor ecosystem.

View source

Similar papers

Review Open access Aug 2026

Metabolic Bottlenecks and Opportunities: Reshaping the Tumor Microenvironment for Cancer Immunotherapy

This review systematically elucidates the complex metabolic interplay between tumor cells and infiltrating T cells, highlighting two defining mechanisms driving immune evasion: the competitive sequestration of essential nutrients and the accumulation of immunosuppressive oncometabolites.

Jia-Ning Zhang, Zi-Mei Tang, Yiran Wang et al. · 0 citations
Review Open access Aug 2026

The role of fumarate and itaconate in tumor microenvironment.

The oncogenic mechanisms of fumarate and itaconate are summarized, viable strategies to address technical hurdles in studying non-enzymatic protein modifications are proposed and new directions for the clinical treatment of tumors are offered through targeted inhibition of fumarate and itaconate.

Yi-Dan Fan, Han-Qiu Zhang, Jinkun Qin et al. · 0 citations
Review Aug 2026

Multidimensional roles of NEDD9 in cancer progression: From molecular regulation to clinical translation.

This review provides a comprehensive and integrative analysis of NEDD9 by systematically linking its structural features, multilayered regulatory mechanisms, diverse biological functions, and clinical relevance within a unified conceptual framework.

Yu Zhang, Lin Li, Ya Zhang et al. · 0 citations
Review Open access Aug 2026

Beyond Glucose and Lipids: The Pivotal Role of Amino Acid Reprogramming in Shaping the Tumor Microenvironment and Guiding the Development of Novel Therapeutics

It is confirmed that amino acid metabolism acts as a core driver of tumor proliferation, immune evasion and therapeutic resistance, and the potential of metabolic-targeted strategies in overcoming drug resistance and improving clinical efficacy is clarified.

Xuan-Hao Wu, Xiao-Dan Mao · 0 citations
Review Open access Sep 2026

Metabolic reprogramming, ferroptosis, and tumor-associated macrophage states: mechanistic crosstalk and therapeutic prospects

A narrative review critically examines the molecular crosstalk through which metabolic and ferroptosis-associated signals may shape macrophage inflammatory, immunoregulatory, tissue-remodeling, and oxidative-stress-associated programs, and discusses potential combinatorial strategies targeting this regulatory axis.

Hu-Chen Hu, Yue-Qi Ma · 0 citations
Review Open access Jul 2026

Protein lactylation in cancer: principles, programmes and therapeutic opportunities.

Inhibition of lactate metabolism markedly attenuates tumor-associated lactylation and exhibits substantial synergistic efficacy when combined with other anti-tumor therapies, providing an important conceptual and theoretical foundation for the development of novel cancer therapeutic strategies targeting protein lactyla...

X. Bu, Xinyue Yu, Jie Wang et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.